ArticleAlzheimer's & dementia (New York, N. Y.)2022

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia.

Nathan Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.